Lawrence F. Eichenfield

Guest Editor for the following articles:

Sep
2017
Vol. 36. No. 3

Atopic dermatitis: addressing allergy, infection, itch and complementary therapies

Adam Friedman, MD | Andrea Waldman, MD | Dawn Marie Davis, MD | Jeffrey Bienstock, MD | Jennifer LeBovidge, PhD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Luz Fonacier, MD | Nathan Jetter, BS | Peter Lio, MD | Peter Y Ong, MD | Sharon E Jacob, MD | Stuart Cohen, MD
This review summarizes allergy, infections, itch in AD, and discusses various alternative and complementary therapies.
MORE
Sep
2017
Vol. 36. No. 3

Atopic dermatitis: phototherapy and systemic therapy

Dawn Marie Davis, MD | Jenna Borok, BS | Jeremy Udkoff, MA | Jonathan Spergel, PhD | Peter Lio, MD
Few studies have compared head-to-head efficacy of the different immunosuppressant therapies such as cyclosporine, methotrexate, azathioprine and mycophenolate mofetil.
MORE
Sep
2017
Vol. 36. No. 3

Atopic dermatitis: emerging therapies

Eric Simpson, MD, MCR | Jenna Borok, BS | Jeremy Udkoff, MA | Lawrence F. Eichenfield, MD | Lisa Beck, MD | Wynnis Tom, MD
We review newly-approved and emerging topical and systemic medications for AD as well as novel early life approaches to preventing the disease onset.
MORE